175 related articles for article (PubMed ID: 37791598)
1. APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
Marino C; Perez-Corredor P; O'Hare M; Heuer A; Chmielewska N; Gordon H; Chandrahas AS; Gonzalez-Buendia L; Delgado-Tirado S; Doan TH; Vanderleest TE; Arevalo-Alquichire S; Obar RA; Ortiz-Cordero C; Villegas A; Sepulveda-Falla D; Kim LA; Lopera F; Mahley R; Huang Y; Quiroz YT; Arboleda-Velasquez JF
Alzheimers Dement; 2024 Feb; 20(2):819-836. PubMed ID: 37791598
[TBL] [Abstract][Full Text] [Related]
2. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
[TBL] [Abstract][Full Text] [Related]
3. Impact of APOE genotype on prion-type propagation of tauopathy.
Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P
Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G
Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
6. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E Recognizes Alzheimer's Disease Associated 3-O Sulfation of Heparan Sulfate.
Mah D; Zhu Y; Su G; Zhao J; Canning A; Gibson J; Song X; Stancanelli E; Xu Y; Zhang F; Linhardt RJ; Liu J; Wang L; Wang C
Angew Chem Int Ed Engl; 2023 Jun; 62(23):e202212636. PubMed ID: 37014788
[TBL] [Abstract][Full Text] [Related]
8. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.
Litvinchuk A; Suh JH; Guo JL; Lin K; Davis SS; Bien-Ly N; Tycksen E; Tabor GT; Remolina Serrano J; Manis M; Bao X; Lee C; Bosch M; Perez EJ; Yuede CM; Cashikar AG; Ulrich JD; Di Paolo G; Holtzman DM
Neuron; 2024 Feb; 112(3):384-403.e8. PubMed ID: 37995685
[TBL] [Abstract][Full Text] [Related]
11. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
[TBL] [Abstract][Full Text] [Related]
12. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
13. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
Ji ZS; Pitas RE; Mahley RW
J Biol Chem; 1998 May; 273(22):13452-60. PubMed ID: 9593678
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
15. Effect of Chronic Cadmium Exposure on Brain and Liver Transporters and Drug-Metabolizing Enzymes in Male and Female Mice Genetically Predisposed to Alzheimer's Disease.
Wang H; Zhang L; Xia Z; Cui JY
Drug Metab Dispos; 2022 Oct; 50(10):1414-1428. PubMed ID: 35878927
[TBL] [Abstract][Full Text] [Related]
16. Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.
Yamauchi Y; Deguchi N; Takagi C; Tanaka M; Dhanasekaran P; Nakano M; Handa T; Phillips MC; Lund-Katz S; Saito H
Biochemistry; 2008 Jun; 47(25):6702-10. PubMed ID: 18507396
[TBL] [Abstract][Full Text] [Related]
17. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
Sepulveda J; Luo N; Nelson M; Ng CAS; Rebeck GW
J Neurochem; 2022 Nov; 163(3):247-259. PubMed ID: 35838553
[TBL] [Abstract][Full Text] [Related]
18. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Roles of
Murakami R; Watanabe H; Hashimoto H; Kashiwagi-Hakozaki M; Hashimoto T; Karch CM; ; Iwatsubo T; Okano H
J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38649269
[TBL] [Abstract][Full Text] [Related]
20. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.
Futamura M; Dhanasekaran P; Handa T; Phillips MC; Lund-Katz S; Saito H
J Biol Chem; 2005 Feb; 280(7):5414-22. PubMed ID: 15583000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
